SCHEMBL7149906

SCHEMBL7149906

CCCCCOC[C@@H](C)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.70
USP2 O75604 1/20 0.61
HTT P42858 2/20 0.59
SPHK1 Q9NYA1 1/20 0.58
TDP1 Q9NUW8 1/20 0.52
LPAR5 Q9H1C0 4/20 0.50
PRKD3 O94806 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
PRKCA P17252 1/20 0.47
PRKCH P24723 1/20 0.47
PRKCI P41743 1/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47
PRKCZ Q05513 1/20 0.47
PRKCD Q05655 1/20 0.47
PRKD1 Q15139 1/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666643 1.00 HSD17B10 (0.70) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL535931 1.00 HSD17B10 (0.70) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL9637036 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL1091934 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL7661581 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL10745894 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL7549303 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL15070143 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL21046009 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1
SCHEMBL186489 0.98 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280753-A1 PROCESS FOR PREPARATION OF R-1-(ARYLOXY)PROPAN-2-OL Rhodia/Chirex, Inc. (US) 2003-02-05 EP claimed
US-6448449-B2 RING OPENING OF (R)-PROPYLENE OXIDE WITH ARYLTRIMETHYLSILYL ETHER IN THE PRESENCE OF AN OPTICALLY ACTIVE CATALYST; REACTING WITH AN ALCOHOL IN THE PRESENCE OF AN ACID; REACTING THE REGIOISOMERIC MIXTURE WITH A TRIARYLMETHYL HALILE; RHODIA CHIREX, INC. 2002-09-10 US claimed
US-20020007090-A1 Process for preparation of (R)-1- (aryloxy)propan-2-ol RHODIA CHIREX, INC. 2002-01-17 US claimed
WO-2001081286-A1 PROCESS FOR PREPARATION OF R-1-(ARYLOXY)PROPAN-2-OL RHODIA/CHIREX, INC. (US) 2001-11-01 WO claimed
EP-1280753-A1 PROCESS FOR PREPARATION OF R-1-(ARYLOXY)PROPAN-2-OL Rhodia/Chirex, Inc. (US) 2003-02-05 EP disclosed
US-6448449-B2 RING OPENING OF (R)-PROPYLENE OXIDE WITH ARYLTRIMETHYLSILYL ETHER IN THE PRESENCE OF AN OPTICALLY ACTIVE CATALYST; REACTING WITH AN ALCOHOL IN THE PRESENCE OF AN ACID; REACTING THE REGIOISOMERIC MIXTURE WITH A TRIARYLMETHYL HALILE; RHODIA CHIREX, INC. 2002-09-10 US disclosed
US-6448449-B2 RING OPENING OF (R)-PROPYLENE OXIDE WITH ARYLTRIMETHYLSILYL ETHER IN THE PRESENCE OF AN OPTICALLY ACTIVE CATALYST; REACTING WITH AN ALCOHOL IN THE PRESENCE OF AN ACID; REACTING THE REGIOISOMERIC MIXTURE WITH A TRIARYLMETHYL HALILE; RHODIA CHIREX, INC. 2002-09-10 US disclosed
US-20020007090-A1 Process for preparation of (R)-1- (aryloxy)propan-2-ol RHODIA CHIREX, INC. 2002-01-17 US disclosed
US-20020007090-A1 Process for preparation of (R)-1- (aryloxy)propan-2-ol RHODIA CHIREX, INC. 2002-01-17 US disclosed
WO-2001081286-A1 PROCESS FOR PREPARATION OF R-1-(ARYLOXY)PROPAN-2-OL RHODIA/CHIREX, INC. (US) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007090-A1 Process for preparation of (R)-1- (aryloxy)propan-2-ol TOP1, POLN, RIF1 HSD17B10 1699/4885USP2 2911/4885HTT 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.